Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-02
1996-03-05
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514301, 514302, 514367, 514375, 514394, 546113, 546114, 546115, 546116, 546118, 548152, 548178, 548224, 5483107, A61K 3144, A61K 31425, A61K 3142, A61K 31415
Patent
active
054968267
ABSTRACT:
New central nervous system agents conform to formula I: ##STR1## wherein R=H or C.sub.1-4 alkoxy;
REFERENCES:
patent: 3586670 (1971-06-01), Brenneisen et al.
patent: 3624100 (1971-11-01), Frick et al.
patent: 3669979 (1972-06-01), Freyermuth
patent: 4038396 (1977-07-01), Shen et al.
patent: 4540648 (1985-09-01), Scheler
patent: 4629740 (1986-12-01), Robertson
patent: 4632939 (1986-12-01), Beedle et al.
patent: 4638014 (1987-01-01), Clark
patent: 4684748 (1987-08-01), Robertson
patent: 4925853 (1990-05-01), Smith et al.
patent: 4981866 (1991-01-01), Beedle et al.
patent: 5151446 (1992-09-01), Horn et al.
patent: 5276051 (1994-01-01), Lesieur et al.
Ortiz Astrid A.
Watson Brett T.
Bristol--Myers Squibb Company
Nolan Sandra M.
Richter Johann
Stockton Laura L.
LandOfFree
Pharmaceutical methods of using heterocyclic derivatives of N-ph does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical methods of using heterocyclic derivatives of N-ph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical methods of using heterocyclic derivatives of N-ph will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1413102